Aurein 1.2
Based on 1 Customer Validation
Aurein 1.2 is a C-terminally amidated antimicrobial peptide found in Litoria raniformis. Aurein 1.2 exhibits moderate, broad-spectrum antimicrobial activity against a variety of bacteria, with a MIC of 12-100 μg/mL. Aurein 1.2 forms an amphipathic α-helix with distinct hydrophilic and hydrophobic faces, and may exert antimicrobial and cytotoxic effects on tumor cells by disrupting cell membranes. Aurein 1.2 can be used in studies related to antimicrobial peptides, membrane-active peptides, and tumor cytotoxicity.
For research use only. We do not sell to patients.
- Purity : 99.21%
- CAS No.: 302343-01-7
- Formula: C71H114N16O18
- Molecular Weight:1479.76
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
All Antibiotic Isoforms
More
Biological Activity
Description
In Vitro
Aurein 1.2 exhibits moderate and relatively broad-spectrum antimicrobial activity, with an MIC of 12 μg/mL against Leuconostoc lactis, an MIC of 50 μg/mL against Staphylococcus aureus, Staphylococcus epidermidis and Streptococcus uberis, an MIC of 100 μg/mL against Bacillus cereus, Listeria innocua, Micrococcus luteus and Pasteurella multocida, and an MIC >100 μg/mL against Escherichia coli[1].
Aurein 1.2 exhibits cytotoxicity against 52 out of 54 human tumor cell lines in the NCI Phase II screening, with an LC50 of 10-5 M against cell panels of lung cancer, colon cancer, central nervous system tumors, melanoma, ovarian cancer, renal cancer, prostate cancer and breast cancer, and an LC50 of 10-4-10-5 M against the leukemia cell panel[1].
Aurein 1.2 causes no significant erythrocyte hemolysis at 100 μg/mL, while the complete hemolysis concentration is 1 mg/mL[1].
Aurein 1.2 (9.7 mM; 70% trifluoroethanol/H2O; pH 2.04; 25°C) forms a regular linear amphipathic α-helix with clearly separated hydrophilic and hydrophobic surfaces in NMR structural analysis[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS No. 302343-01-7
-
Appearance Solid
-
Molecular Weight 1479.76
-
Formula C71H114N16O18
-
Color White to off-white
-
Sequence
Gly-Leu-Phe-Asp-Ile-Ile-Lys-Lys-Ile-Ala-Glu-Ser-Phe-NH2
-
Sequence Shortening
GLFDIIKKIAESF-NH2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (67.58 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (272 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.6758 mL | 3.3789 mL | 6.7579 mL | 16.8946 mL |
| 5 mM | 0.1352 mL | 0.6758 mL | 1.3516 mL | 3.3789 mL | |
| 10 mM | 0.0676 mL | 0.3379 mL | 0.6758 mL | 1.6895 mL | |
| 15 mM | 0.0451 mL | 0.2253 mL | 0.4505 mL | 1.1263 mL | |
| 20 mM | 0.0338 mL | 0.1689 mL | 0.3379 mL | 0.8447 mL | |
| 25 mM | 0.0270 mL | 0.1352 mL | 0.2703 mL | 0.6758 mL | |
| 30 mM | 0.0225 mL | 0.1126 mL | 0.2253 mL | 0.5632 mL | |
| 40 mM | 0.0169 mL | 0.0845 mL | 0.1689 mL | 0.4224 mL | |
| 50 mM | 0.0135 mL | 0.0676 mL | 0.1352 mL | 0.3379 mL | |
| 60 mM | 0.0113 mL | 0.0563 mL | 0.1126 mL | 0.2816 mL |